<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">MECLIZINE HYDROCHLORIDE <img border="0" src="../images/pr.gif"/></span><br/>(mek'li-zeen)<br/><span class="topboxtradename">Antivert, </span><span class="topboxtradename">Antrizine, </span><span class="topboxtradename">Bonamine <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Bonine, </span><span class="topboxtradename">Dizmiss, </span><span class="topboxtradename">RuVert-M<br/></span><b>Classifications:</b> <span class="classification">antihistamine</span>; <span class="classification">h<sub>1</sub>-receptor antagonist</span>; <span class="classification">anti-vertigo agent</span><br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>12.5 mg, 25 mg, 50 mg tablets; 25 mg, 30 mg capsules</p>
<h1><a name="action">Actions</a></h1>
<p>Long-acting piperazine antihistamine, structurally and pharmacologically related to cyclizine compounds. Marked effect in
         blocking histamine-induced vasopressive response but only slight anticholinergic action. Marked depressant action on labyrinthine
         excitability and on conduction in vestibular-cerebellar pathways.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Exhibits CNS depression, antispasmodic, antiemetic, and local anesthetic activity.</p>
<h1><a name="uses">Uses</a></h1>
<p>Management of nausea, vomiting, and dizziness associated with motion sickness and in vertigo associated with diseases affecting
         vestibular system.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to meclizine; pregnancy (category B).</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Angle-closure glaucoma, prostatic hypertrophy. Safety in lactation or children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Motion Sickness</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 2550 mg 1 h before travel, may repeat q24h if necessary for duration of journey<br/><br/><span class="indicationtitle">Vertigo</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 25100 mg/d in divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give without regard to meals.</li>
<li>Ensure that chewable tablets are chewed or crushed before being swallowed with a liquid.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> <span class="speceff-common">Drowsiness.</span> <span class="typehead">GI:</span> Dry mouth. <span class="typehead">Special Senses:</span> Blurred vision. <span class="typehead">Body as a Whole:</span> Fatigue. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>alcohol,</b> <span class="classification">cns depressants</span> may potentiate sedative effects of meclizine. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 1 h. <span class="typehead">Duration:</span> 824 h. <span class="typehead">Distribution:</span> Crosses placenta. <span class="typehead"> Elimination:</span> Excreted primarily in feces. <span class="typehead">Half-Life:</span> 6 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Supervision of ambulation, particularly with the older adult, since drug may cause drowsiness.</li>
<li>Assess effectiveness of drug and inform physician when prescribed for vertigo; dosage adjustment may be required.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not drive or engage in potentially hazardous activities until response to drug is known.</li>
<li>Be aware that sedative action may add to that of alcohol, barbiturates, narcotic analgesics, or other CNS depressants.</li>
<li>Take 1 h before departure when prescribed for motion sickness.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>